Joshua D. I. Ellenhorn

Suggest Changes
Learn More
Purpose: To conduct a phase I trial of a Modified Vaccinia Ankara vaccine delivering wild-type human p53 (p53MVA) in combination with gemcitabine chemotherapy in patients with platinum-resistant(More)
  • 1